Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNeuropharmacology

Inhibition of Plasma Membrane Na/Ca-Exchanger by KB-R7943 or Lithium Reveals Its Role in Ca-Dependent N-methyl-d-aspartate Receptor Inactivation

Dmitry A. Sibarov, Polina A. Abushik, Ekaterina E. Poguzhelskaya, Konstantin V. Bolshakov and Sergei M. Antonov
Journal of Pharmacology and Experimental Therapeutics December 2015, 355 (3) 484-495; DOI: https://doi.org/10.1124/jpet.115.227173
Dmitry A. Sibarov
Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, St. Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dmitry A. Sibarov
Polina A. Abushik
Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, St. Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ekaterina E. Poguzhelskaya
Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, St. Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantin V. Bolshakov
Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, St. Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergei M. Antonov
Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, St. Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sergei M. Antonov
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Chemical structure of KB-R7943.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    The voltage independence of inhibition of NMDA-induced current by 10 μM KBR. (A) Whole-cell currents induced by 30 μM NMDA + 30 μM Gly in the absence and presence of 10 μM KBR recorded at −85 and +45 mV. Application protocols are indicated above the records. (B) The I-V relations of NMDAR currents induced by 30 μM NMDA + 30 μM Gly in the absence and the presence of 10 μM KBR within the range of Vm values from −60 to +50 mV. The insert shows the applied voltage ramp protocol. (C) The fraction of NMDA-induced currents inhibited by 10 μM KBR at several Vm values (−85, −55, −25, and +45 mV). Protocol of measurements was similar to those indicated in (A). The mean values ± S.E.M. from five experiments are plotted.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    The KBR inhibition of native and recombinant NMDARs. (A and B) Currents evoked by 30 μM NMDA + 30 μM Gly in the absence and the presence of 10 μM KBR or 1 μM ifenprodil (Ifen) in cortical neurons at Vm = −55 mV. Application protocols are indicated above the records. (C and D) Currents evoked by 30 μM NMDA + 30 μM Gly in the absence and presence of 10 μM KBR in HEK293T cells expressing GluN1/2A (C) and GluN1/2B (D) NMDARs at Vm = −35 mV. Application protocols are indicated above the records. (E) Quantitative comparison of 10 μM KBR inhibition of currents activated by 30 μM NMDA + 30 μM Gly mediated by native NMDARs (Ifen-sensitive and Ifen-resistant, n = 5 for each group) and recombinant NMDARs of GluN1/2A and GluN/2B subunit compositions (HEK293T cells, n = 3 for each group). Ordinate represents the relative inhibition of currents by 10 μM KBR measured as (1 − INMDA+KBR/INMDA), where INMDA (pA) is an amplitude of current in the absence of KBR and INMDA+KBR (pA) is an amplitude of current in the presence of KBR. The mean values ± S.E.M. are plotted. Data do not differ significantly (P > 0.2, ANOVA).

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    The KBR block of NMDARs depends on glycine concentration. (A) Currents elicited by 30 μM NMDA in the presence of 1 μM (left) and 300 μM glycine (right) recorded in the presence of the indicated KBR concentrations at Vm = −55 mV. Application protocols are indicated above the records. (B) KBR concentration-inhibition curves for currents activated by 30 μM NMDA in the presence of the indicated glycine concentrations (1, 30, and 300 μM). The mean values ± S.E.M. from four experiments for each condition are plotted. Solid lines indicate fits of the data with the Hill equation with the following parameters: for 1 μM Gly, KBR IC50 = 5.3 ± 0.1 μM and Hill coefficient (h) = 2.7 ± 0.3; for 30 μM Gly, IC50 = 15.0 ± 1.2 μM and h = 2.0 ± 0.1; and for 300 μM Gly, IC50 = 41.2 ± 8.8 μM and h = 1.0 ± 0.1. The IC50 values are significantly different for all Gly concentrations under study (P < 0.01, ANOVA, post-hoc Bonferroni test). (C) KBR concentration-inhibition curves for currents activated by 10, 30, and 100 μM NMDA in the presence of 30 μM glycine. The mean values ± S.E.M. from four experiments for each condition are plotted. Solid lines indicate fits of the data with the Hill equation. KBR IC50 values were 12.9 ± 1.5 μM (h = 1.8 ± 0.2), 15.0 ± 1.2 μM (h = 1.8 ± 0.2), and 15.6 ± 1.2 μM (h = 1.9 ± 0.4) for 10, 30, and 100 μM NMDA, respectively, and did not differ significantly (P > 0.4, ANOVA).

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Relief from KBR inhibition by increasing the Gly concentration. (A) Currents elicited by applications of 30 μM NMDA + 30 μM Gly and 1 μM Gly (1), 30 μM Gly (2), and 300 μM Gly (3) in the presence of 30 μM NMDA + 10 μM KBR recorded at Vm = −55 mV in a neuron. Application protocols are shown above the trace. The insert represents an overlay of Gly-induced currents replotted at a higher time resolution. (B) Currents elicited by applications of 30 μM NMDA + 30 μM Gly and 30 μM Gly (1), 100 μM Gly (2) in the presence of 30 μM NMDA + 10 μM KBR, and 100 μM Gly (3) in the presence of 30 μM NMDA + 33 μM KBR recorded at Vm = −55 mV in a neuron. Application protocols are shown above the trace by solid lines. The insert represents an overlay of Gly-induced currents replotted at a higher time resolution.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Dependence of currents elicited by NMDA + KBR on extracellular Ca2+. (A) Currents recorded in a neuron at Vm = −55 mV elicited by application of KBR alone or NMDA alone, their simultaneous application (NMDA + KBR), and application of NMDA + Gly. Application protocols are shown above the trace. (B) NMDA + KBR elicited currents recorded in a neuron at Vm = −55 mV in the presence and absence of Ca2+ in the external bathing solution. Application protocols are shown above the trace by solid lines. (C) Currents recorded in the same neuron at Vm = −55 mV elicited by NMDA + KBR (left record) and NMDA + Gly (right record) in the Ca2+-free solution. KBR (10 µM) was added for a short episode in the middle of NMDA + Gly application. Application protocols are shown above the trace. (D) The NMDAR-mediated current activated by 100 μM NMDA + 10 μM KBR in a neuron at Vm = ;−55 mV in the Ca2+-free solutions. Kynurenate (Kyn; 50 µM) was added for a short episode in the middle of NMDA + KBR application. The application protocol is shown above the trace. (E) Currents activated by 30 μM NMDA + 10 μM KBR in a neuron at Vm = −55 mV in the presence of 1 mM Ca2+ in the external bathing solution (left record) and in the Ca2+-free solutions (right record). Ca2+ (1 mM) was added for a short episode in the middle of NMDA + KBR application. Application protocols are shown above the trace by solid lines. (F) Quantitative comparison of steady-state amplitudes of currents activated by 30 μM NMDA + 10 μM KBR in neurons in the absence (n = 7) and presence (n = 7) of 1 mM Ca2+ in the external bathing solution and when 1 mM Ca2+ is applied for a short period of time (n = 3). *Data differ significantly (P < 0.0001, ANOVA, post-hoc Bonferroni test). (G) NMDAR-mediated currents activated by 100 μM NMDA + 10 μM KBR and 100 μM NMDA + 10 μM Gly in a neuron at Vm = −55 mV loaded with BAPTA in the presence of 1 mM Ca2+ in the external bathing solution and in the Ca2+-free media. (H) Quantitative comparison of steady-state amplitudes of currents activated by 100 μM NMDA + 10 μM KBR and 100 μM NMDA + 10 μM Gly in BAPTA-loaded neurons in the absence (n = 6) and presence (n = 6) of 1 mM Ca2+ in the external bathing solution. Data do not differ significantly (P > 0.1, ANOVA). The mean amplitude for four recorded currents (G) in each experiment was taken for 100%.

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Li+ enhances Ca2+ inactivation of NMDAR currents. (A) Currents activated by 30 μM NMDA + 10 μM Gly in a neuron at Vm = −55 mV in the presence and absence of 1 mM Ca2+ in Na+ and Li+ external bathing solutions. Application protocols are shown above the trace by solid lines and boxes. (B) Superposition of currents depicted in (A) under certain conditions (currents indicated by different colors) for better comparison of their time courses. (C) Quantitative comparison of amplitudes of currents activated by 30 μM NMDA + 10 μM Gly measured at the steady state in the absence (n = 5) and presence (n = 5) of 1 mM Ca2+ in Na+ and Li+ external bathing solutions. *Data differ significantly (P < 0.01, Student’s two-tailed t tests).

  • Fig. 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    Measurements of EC50 of KBR as a coagonist of NMDARs. (A) An overlay of currents elicited by NMDA + KBR at different concentrations (shown on the right of each trace) in a neuron at Vm = −55 mV in Ca2+-free solution. (B) Concentration-activation curve for KBR of currents elicited by 30 μM NMDA recorded in neurons at Vm = −55 mV in Ca2+-free external solution. The mean values ± S.E.M. from five experiments for each condition are plotted. Solid line indicates fit of the data with the Hill equation. Fit reveals the following parameters of KBR activation: EC50 = 1.18 ± 0.16 µM and h = 1.5 ± 0.4. KBR concentrations above 10 μM were not used for the fit. (C) NMDAR-mediated currents activated by 100 μM NMDA + 10 μM KBR and 100 μM NMDA + 10 μM Gly in a neuron at Vm = −55 mV in the Ca2+-free media. (D) Quantitative comparison of amplitudes of currents activated by 100 µM NMDA + 10 µM KBR and by 100 µM NMDA + 10 µM Gly recorded on the same neurons (n = 7) during paired applications in the Ca2+-free media. The mean values ± S.E.M. are plotted. Data do not differ significantly (P > 0.7, two-tailed Student’s t test). (E) Currents recorded in a neuron at Vm = −55 mV in Ca2+-free external solution elicited by successive applications of 30 μM NMDA + KBR at 3, 10, 30, and 100 μM. Application protocol is shown above the trace.

  • Fig. 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 9.

    Schematics of the data interpretation. (A) Control conditions when Ca2+ entry from Ca2+-containing extracellular solution in neurons through NMDAR channels activated by NMDA (N) + Gly is partly compensated by the NCX Ca2+ extrusion. Typical shape of currents in these conditions is indicated to the right of the illustration. (B) In the presence of extracellular Ca2+, NMDA + KBR activates NMDAR and Ca2+ entry in the cytoplasm through the channels and inhibits Ca2+ extrusion by the NCX, which causes Ca2+ elevation around intracellular domains of NMDARs and enforces their Ca2+-dependent inactivation. Typical shape of currents in these conditions is indicated to the right of the illustration. (C and D) In the Ca2+-free extracellular solution, independent of whether the NMDARs are activated with Gly (C) or KBR (D), Ca2+ does not enter the cytoplasm and currents do not reveal desensitization. (E) In the presence of Ca2+ in the extracellular solutions, neurons loaded with BAPTA when NMDARs are activated by NMDA (N) and KBR do not reveal current desensitization since BAPTA bind Ca2+ that enter the cytoplasm through the NMDAR channels. In the illustration, INMDA is the current activated by NMDA + Gly or KBR. Other symbols have their usual meanings. For further explanation, see Discussion.

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 355 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 355, Issue 3
1 Dec 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Plasma Membrane Na/Ca-Exchanger by KB-R7943 or Lithium Reveals Its Role in Ca-Dependent N-methyl-d-aspartate Receptor Inactivation
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNeuropharmacology

Mechanism of KB-R7943 and Lithium Effects on NMDARs

Dmitry A. Sibarov, Polina A. Abushik, Ekaterina E. Poguzhelskaya, Konstantin V. Bolshakov and Sergei M. Antonov
Journal of Pharmacology and Experimental Therapeutics December 1, 2015, 355 (3) 484-495; DOI: https://doi.org/10.1124/jpet.115.227173

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleNeuropharmacology

Mechanism of KB-R7943 and Lithium Effects on NMDARs

Dmitry A. Sibarov, Polina A. Abushik, Ekaterina E. Poguzhelskaya, Konstantin V. Bolshakov and Sergei M. Antonov
Journal of Pharmacology and Experimental Therapeutics December 1, 2015, 355 (3) 484-495; DOI: https://doi.org/10.1124/jpet.115.227173
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CVN424, a novel GPR6 inverse agonist for Parkinson's disease
  • Methylone Brain Concentrations and Pharmacodynamic Effects
  • Oxysterols and Ethanol
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics